• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2021 Jan 5;8(2):ofab007.
doi: 10.1093/ofid/ofab007. eCollection 2021 Feb.
The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study


Paul W Blair[SUP] 1 2 [/SUP], Diane M Brown[SUP] 1 [/SUP], Minyoung Jang[SUP] 1 [/SUP], Annukka A R Antar[SUP] 1 [/SUP], Jeanne C Keruly[SUP] 1 [/SUP], Vismaya S Bachu[SUP] 1 [/SUP], Jennifer L Townsend[SUP] 1 [/SUP], Jeffrey A Tornheim[SUP] 1 [/SUP], Sara C Keller[SUP] 1 [/SUP], Lauren Sauer[SUP] 3 [/SUP], David L Thomas[SUP] 1 [/SUP], Yukari C Manabe[SUP] 1 [/SUP], Ambulatory COVID Study Team



Collaborators, Affiliations

Abstract

Background: Outpatient coronavirus disease 2019 (COVID-19) has been insufficiently characterized. To determine the progression of disease and determinants of hospitalization, we conducted a prospective cohort study.
Methods: Outpatient adults with positive reverse transcription polymerase chain reaction results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were recruited by phone between April 21 and July 23, 2020, after receiving outpatient or emergency department testing within a large health network in Maryland, United States. Symptoms were collected by participants on days 0, 3, 7, 14, 21, and 28, and portable pulse oximeter oxygen saturation (SaO[SUB]2[/SUB]), heart rate, and temperature were collected for 15 consecutive days. Baseline demographics, comorbid conditions, and vital signs were evaluated for risk of subsequent hospitalization using negative binomial and logistic regression.
Results: Among 118 SARS-CoV-2-infected outpatients, the median age (interquartile range [IQR]) was 56.0 (50.0-63.0) years, and 50 (42.4%) were male. Among individuals in the first week of illness (n = 61), the most common symptoms included weakness/fatigue (65.7%), cough (58.8%), headache (45.6%), chills (38.2%), and anosmia (27.9%). Participants returned to their usual health a median (IQR) of 20 (13-38) days from symptom onset, and 66.0% of respondents were at their usual health during the fourth week of illness. Over 28 days, 10.9% presented to the emergency department and 7.6% required hospitalization. The area under the receiver operating characteristics curve for the initial home SaO[SUB]2[/SUB] for predicting subsequent hospitalization was 0.86 (95% CI, 0.73-0.99).
Conclusions: Symptoms often persisted but uncommonly progressed to hospitalization among outpatients with COVID-19. Home SaO[SUB]2[/SUB] may be a helpful tool to stratify risk of hospitalization.

Keywords: ambulatory care; coronavirus infections/epidemiology; middle aged; recovery of function; treatment outcome.
 
Back
Top Bottom